Regis Healthcare Limited reaffirmed is earnings for the fiscal year 2020. The company is reaffirming its guidance that financial year 2020, EBITDA and NPAT are forecast to be circa $92 million pre-AASB 16 and $28 million, respectively, on an underlying basis.